Clinical trial
Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable…
NCT00233636 · AstraZeneca, Industry · Withdrawn
Key facts
| NCT number | NCT00233636 |
|---|---|
| Title | Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck |
| Official title | A 2 Part Phase 2 Trial to Evaluate ZD1839 (Iressa™) & Radiotherapy in Patients w/Locally Advanced Inoperable Squamous Cell Carcinoma of the Head & Neck |
| Lead sponsor | AstraZeneca, Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer, Carcinoma, Squamous Cell |
| Intervention type | Drug, Procedure |
| Interventions | Iressa (Gefitinib), Radiotherapy |
| Enrollment | 28 |
| Start date | Jul 1, 2003 |
| First posted | Oct 6, 2005 |
| Last update posted | Jan 27, 2011 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: